MTSS1 hypermethylation is associated with prostate cancer progression

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• Prostate cancer (PCa) progression is influenced by genetic and epigenetic alterations.
• Metastasis suppressor 1 (MTSS1) is a gene involved in cell motility and tumor suppression.
• Aberrant DNA methylation is a key epigenetic mechanism in cancer development.

Purpose of the Study:

• To investigate the role of MTSS1 DNA methylation in prostate cancer progression.
• To determine the relationship between MTSS1 methylation status and its expression levels in PCa.
• To evaluate the functional impact of MTSS1 alterations on PCa cell behavior and tumor growth.

Main Methods:

• Analysis of 49 paired PCa and normal tissue samples from The Cancer Genome Atlas.
• Methylome analysis, CpG island arrays, and hierarchical clustering for methylation profiling.
• Methylation-specific PCR, qRT-PCR, Western blot, cell-based assays (migration, invasion, proliferation, cell cycle), and in vivo tumor xenograft assays.

Main Results:

• MTSS1 expression was significantly decreased in PCa tissues compared to normal tissues.
• PCa tissues exhibited hypermethylation of MTSS1 compared to normal tissues.
• MTSS1 demethylation inhibited PCa cell migration, invasion, and proliferation, and induced G0/G1 cell cycle arrest.
• In vivo studies confirmed that MTSS1 inhibits tumor growth.

Conclusions:

• Hypermethylation of MTSS1 is a significant epigenetic event in prostate cancer.
• Reduced MTSS1 expression due to hypermethylation promotes PCa cell migration, invasion, proliferation, and tumor growth.
• MTSS1 acts as a tumor suppressor in prostate cancer, and its epigenetic silencing contributes to disease progression.